Literature DB >> 22372498

Molecular mechanisms of pancreatic cancer dissemination: the role of the chemokine system.

Federica Marchesi1, Fabio Grizzi, Luigi Laghi, Alberto Mantovani, Paola Allavena.   

Abstract

Over the last decade it has been established that cancer-associated inflammation affects many aspects of malignancy and in particular endorses tumor cell survival, proliferation and distant spread. Chemokines and their receptors are major players of the cancerrelated inflammation. Our understanding of the chemokine role in tumor biology now ranges from their ability to recruit blood leukocytes within tumors, to direct effects on cancer cell survival, metastatization and regulation of angiogenesis. Chemokines and their receptors are expressed in human pancreatic adenocarcinoma and are involved in its malignant behavior. Notably, the receptor CX3CR1 favors tumor perineural tropism which is typical of this neoplasm and is associated with early recurrence after surgery and with poor patient prognosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22372498     DOI: 10.2174/13816128112092432

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  8 in total

1.  Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment.

Authors:  Jonas Rm Van Audenaerde; Elly Marcq; Bianca von Scheidt; Ashleigh S Davey; Amanda J Oliver; Jorrit De Waele; Delphine Quatannens; Jinthe Van Loenhout; Patrick Pauwels; Geert Roeyen; Filip Lardon; Clare Y Slaney; Marc Peeters; Michael H Kershaw; Phillip K Darcy; Evelien Ljm Smits
Journal:  Clin Transl Immunology       Date:  2020-08-15

Review 2.  Regulation of development and cancer by the R2B subfamily of RPTPs and the implications of proteolysis.

Authors:  Sonya E L Craig; Susann M Brady-Kalnay
Journal:  Semin Cell Dev Biol       Date:  2014-09-16       Impact factor: 7.727

Review 3.  Chemokine receptors in epithelial ovarian cancer.

Authors:  Goda G Muralidhar; Maria V Barbolina
Journal:  Int J Mol Sci       Date:  2013-12-31       Impact factor: 5.923

4.  Selected cytokines in patients with pancreatic cancer: a preliminary report.

Authors:  Wojciech Błogowski; Anna Deskur; Marta Budkowska; Daria Sałata; Anna Madej-Michniewicz; Krzysztof Dąbkowski; Barbara Dołęgowska; Teresa Starzyńska
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

5.  Low dose irradiation increases adoptive cytotoxic T lymphocyte migration in gastric cancer.

Authors:  Juan Du; Shu Su; Hongyan Li; Jie Shao; Fanyan Meng; Mi Yang; Hanqing Qian; Zhengyun Zou; Xiaoping Qian; Baorui Liu
Journal:  Exp Ther Med       Date:  2017-10-13       Impact factor: 2.447

6.  Canonical and alternative transcript expression of PAX6 and CXCR4 in pancreatic cancer.

Authors:  Elizabeth C Little; Jennifer D Kubic; Ravi Salgia; Paul J Grippo; Deborah Lang
Journal:  Oncol Lett       Date:  2017-03-29       Impact factor: 2.967

7.  Clinical significance and prospective molecular mechanism of C‑C motif chemokine receptors in patients with early‑stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.

Authors:  Xin Zhou; Xiwen Liao; Xiangkun Wang; Ketuan Huang; Chengkun Yang; Tingdong Yu; Junqi Liu; Chuangye Han; Guangzhi Zhu; Hao Su; Wei Qin; Quanfa Han; Zhengqian Liu; Jianlv Huang; Yizhen Gong; Xinping Ye; Tao Peng
Journal:  Oncol Rep       Date:  2019-08-13       Impact factor: 3.906

8.  Adhesion of Gastric Cancer Cells to the Enteric Nervous System: Comparison between the Intestinal Type and Diffuse Type of Gastric Cancer.

Authors:  Paul Girot; Nicolas Chapelle; Laetitia Aymeric; Anne Bessard; Alice Prigent; Yann Touchefeu; Christine Varon; Michel Neunlist; Emilie Duchalais; Tamara Matysiak-Budnik
Journal:  Cancers (Basel)       Date:  2022-07-06       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.